Advertisement

European Journal of Clinical Pharmacology

, Volume 59, Issue 8–9, pp 677–684 | Cite as

Prescription and non-prescription medicine use in Denmark: association with socio-economic position

  • Merete W. NielsenEmail author
  • Ebba Holme Hansen
  • Niels Kristian Rasmussen
Pharmacoepidemiology and Prescription

Abstract

Objective

To analyse the association among different types of medicine use and different measures of socio-economic position (SEP) in one and the same general population.

Methods

Data from The Danish Health and Morbidity Survey 2000 were analysed. The survey was conducted by face-to-face interviews with a representative sample of the adult Danish population (n=16,690). The associations between prescription and over-the-counter (OTC) medicine use and education, occupation and income were assessed by logistic regression analyses. All analyses were adjusted for age, gender and two measures of health status.

Results

This cross-sectional analysis of medicine use in a large representative sample of the Danish population found greater use of prescription medicines among disability pensioners and “others” than in salaried employees. Disability pensioners and self-employed individuals used less OTC medicine than salaried employees. Individuals with low income used more prescription medicines but not more OTC medicines, than those with high income. No major differences were found in prescription medicine use with respect to education, but men within the two middle educational groups tended to use prescription medicine less frequently than both lower and higher educated men. A similar trend was not found for women. OTC medicine use was not associated with education for either gender.

Conclusions

The prevalence of prescription medicine use increases with declining SEP, after adjusting for health status. Such an association does not exist for OTC medicine use. The results show that the least affluent have access to prescription medicine. The difference between prescription and OTC medicine use may be explained by a compensation mechanism.

Keywords

Socio-economic position Prescription medicine Over-the-counter medicine 

Notes

Acknowledgements

The authors would like to thank Ola Ekholm, National Institute of Public Health, for statistical support during the analyses. Data collection was funded by a grant from The Danish Ministry of Health and a Ph.D. fellowship from The Danish University of Pharmaceutical Sciences.

References

  1. 1.
    Lynch J, Kaplan G (2000) Socioeconomic position. In: Berkman LF, Kawachi I (eds) Social Epidemiology. Oxford University Press, New York, pp 13–35Google Scholar
  2. 2.
    van der Meer JBW, van den Bos J, Mackenbach JP (1996) Socioeconomic differences in the utilization of health services in a Dutch population: the contribution of health status. Health Policy 37:1–18CrossRefPubMedGoogle Scholar
  3. 3.
    Rosholm JU, Christensen K (1997) Relationship between drug use and self-reported health in elderly Danes. Eur J Clin Pharmacol 53:179–183CrossRefPubMedGoogle Scholar
  4. 4.
    Furu K, Straume B, Thelle DS (1997) Legal drug use in a general population: association with gender, morbidity, health care utilization, and lifestyle characteristics. J Clin Epidemiol 50:341–349CrossRefPubMedGoogle Scholar
  5. 5.
    Eggen AE (1994) Pattern of drug use in a general population—prevalence and predicting factors: The Tromsø Study. Int J Epidemiol 23:1262–1272Google Scholar
  6. 6.
    Wisborg GB, Claesson CB, Lundberg O, Thorslund M (1996) Drug usage and self-reported health among a cross-sectional population aged over 75 years. Clin Drug Invest 12:156–169Google Scholar
  7. 7.
    Muratet C, for the Service Médical Interentreprises de la Région de Toulouse, Lapeyre-Mestre M, Montastruc JL (1995) Study on the regular use of drugs in workers over 50 years of age. Clin Drug Invest 9:1–7Google Scholar
  8. 8.
    Henricson K, Stenberg P, Rametsteiner G, Ranstam J, Hanson BS, Melander A (1998) Socioeconomic factors, morbidity and drug utilization—an ecological study. Pharmacoepidemiol Drug Saf 7:261–267CrossRefGoogle Scholar
  9. 9.
    Metge C, Black C, Peterson S, Kozyrskyj AL (1999) The population’s use of pharmaceuticals. Med Care 37:JS42-JS59CrossRefPubMedGoogle Scholar
  10. 10.
    Antonov KI, Isacson DG (1998) Prescription and nonprescription analgesic use in Sweden. Ann Pharmacother 32:485–494PubMedGoogle Scholar
  11. 11.
    Merlo J, Lynch JW, Yang M, Lindstrom M, Östergren PO, Rasmussen NK, Rastam L (2003) Effect of neighborhood social participation on individual use of hormone replacement therapy and antihypertensive medication: a multilevel analysis. Am J Epidemiol 157:774–783CrossRefPubMedGoogle Scholar
  12. 12.
    Fillenbaum GG, Hanlon JT, Corder EH, Ziqubu-Page T, Wall WE Jr, Brock D (1993) Prescription and nonprescription drug use among black and white community-residing elderly. Am J Public Health 83:1577–1582PubMedGoogle Scholar
  13. 13.
    Johnson RE, Pope CR (1983) Health status and social factors in nonprescribed drug use. Med Care XXI: 225–233Google Scholar
  14. 14.
    Vallgårda S, Krasnik A, Vrangbaek K (2001) Health care systems in transition—Denmark 2001. European Observatory on Health Care Systems, CopenhagenGoogle Scholar
  15. 15.
    The Danish Medicines Agency. (2003) Title: Udgiftsgraenser [Limits of expenditure] Available at:http://www.laegemiddelstyrelsen.dk/tilskud/overblik/sidste_nyt/tilskud010103.asp. Cited 14 July 2003
  16. 16.
    Kjøller M, Rasmussen NK (2002) Danish Health and Morbidity Survey 2000......& trends since 1987 (in Danish). Statens Institut for Folkesundhed, CopenhagenGoogle Scholar
  17. 17.
    UNESCO (1997) International Standard Classification of Education ISCED 1997. United Nations Educational, Scientific and Cultural Organization (UNESCO)Google Scholar
  18. 18.
    Eggen AE (1997) Patterns of medicine use in a general population (0–80 years). The influence of age, gender, diseases and place of residence on drug use in Norway. Pharmacoepidemiol Drug Saf 6:179–187CrossRefGoogle Scholar
  19. 19.
    Ashton H, Golding JF (1989) Tranquillisers: prevalence, predictors and possible consequences. Data from a large United Kingdom survey. Br J Addiction 84:541–546Google Scholar
  20. 20.
    Fichter MM, Witzke W, Leibl K, Hippius H (1989) Psychotropic drug use in a representative community sample: the Upper Bavarian study. Acta Psychiatr Scand 80:68–77PubMedGoogle Scholar
  21. 21.
    Pakesch G, Loimer N, Rasinger E, Tutsch G, Katschnig H (1989) The prevalence of psychoactive drug intake in a metropolitan population. Pharmacopsychiatry 22:61–65PubMedGoogle Scholar
  22. 22.
    Riska E, Klaukka T (1984) Use of psychotropic drugs in Finland. Soc Sci Med 19:983–989CrossRefGoogle Scholar
  23. 23.
    Weyerer S, Dilling H (1991) Psychiatric and physical illness, sociodemographic characteristics, and the use of psychotropic drugs in the community: results from the Upper Bavarian Field Study. J Clin Epidemiol 44:303–311PubMedGoogle Scholar
  24. 24.
    Eggen AE (1993) The Tromso Study: frequency and predicting factors of analgesic drug use in a free-living population (12–56 years). J Clin Epidemiol 46:1297–1304PubMedGoogle Scholar
  25. 25.
    Furu K, Straume B (1999) Use of antacids in a general population: the impact of health-related variables, lifestyle and sociodemographic characteristics. J Clin Epidemiol 52:509–516CrossRefPubMedGoogle Scholar
  26. 26.
    Thomas HF, Sweetnam PM, Janchawee B, Luscombe DK (1999) Polypharmacy among older men in South Wales. Eur J Clin Pharmacol 55:411–415CrossRefPubMedGoogle Scholar
  27. 27.
    Liberatos P, Link BG, Kelsey JL (1988) The measurement of social class in epidemiology. Epidemiol Rev 10:87–121PubMedGoogle Scholar
  28. 28.
    Wilkinson GR (1999) Putting the picture together: prosperity, redistribution, health, and welfare. In: Marmot M, Wilkinson GR (eds) Social determinants of health. Oxford University Press, Oxford, pp 256–274Google Scholar
  29. 29.
    Lahelma E, Kivela K, Roos E, Tuominen T, Dahl E, Diderichsen F, Elstad JI et al. (2002) Analysing changes of health inequalities in the Nordic welfare states. Soc Sci Med 55:609–625CrossRefGoogle Scholar
  30. 30.
    Reijneveld SA, Stronks K (2001) The validity of self-reported use of health care across socioeconomic strata: a comparison of survey and registration data. Int J Epidemiol 30:1407–1414CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2003

Authors and Affiliations

  • Merete W. Nielsen
    • 1
    • 2
    • 4
    Email author
  • Ebba Holme Hansen
    • 1
    • 2
  • Niels Kristian Rasmussen
    • 2
    • 3
  1. 1.Department of Social PharmacyThe Danish University of Pharmaceutical SciencesDenmark
  2. 2.FKL—Research Centre for Quality in Medicine UseDenmark
  3. 3.National Institute of Public HealthCopenhagenDenmark
  4. 4.Department of Social PharmacyThe Danish University of Pharmaceutical SciencesCopenhagenDenmark

Personalised recommendations